| 1 |
selective serotonin reuptake inhibitor
(2399 times)
|
Psychiatry
(586 times)
|
MDD (172 times)
SNRI (153 times)
TCA (102 times)
|
1992 Inhibitors of imipramine metabolism by human liver microsomes.
|
| 2 |
serotonin selective reuptake inhibitor
(102 times)
|
Psychiatry
(30 times)
|
SNRI (9 times)
TCA (9 times)
MDD (7 times)
|
1993 SSRI-associated nocturnal bruxism in four patients.
|
| 3 |
selective 5-HT reuptake inhibitors
(12 times)
|
Pharmacology
(5 times)
|
ASA (1 time)
DH (1 time)
DOM (1 time)
|
1994 Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function.
|
| 4 |
selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor
(9 times)
|
Drug Therapy
(6 times)
|
TCA (2 times)
4-AP (1 time)
CIT (1 time)
|
1997 Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
|
| 5 |
selective serotonin reuptake inhibitors antidepressants
(7 times)
|
Mental Disorders
(2 times)
|
AD (1 time)
ERK (1 time)
HALO (1 time)
|
1998 [Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
|
| 6 |
Schutte Self-Report Inventory
(3 times)
|
Sports Medicine
(1 time)
|
EI (2 times)
MC (1 time)
STAI (1 time)
|
2007 Trait emotional intelligence and leadership self-efficacy: their relationship with collective efficacy.
|
| 7 |
symptom score reducing indices
(3 times)
|
Complementary Therapies
(2 times)
|
CP (1 time)
HC (1 time)
HS (1 time)
|
2004 [Clinical effect of escin on patients with cutaneous pruritus caused by blood stasis and wind-dryness].
|
| 8 |
selective serotonin reuptake agent
(2 times)
|
Neurology
(2 times)
|
CGI (1 time)
HDRS (1 time)
|
2004 Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response.
|
| 9 |
selective serotonin reuptake inhibitor medication
(2 times)
|
Behavioral Sciences
(1 time)
|
AUD (1 time)
hdPS (1 time)
PTSD (1 time)
|
2018 Perinatal selective serotonin reuptake inhibitor medication (SSRI) effects on social behaviors, neurodevelopment and the epigenome.
|
| 10 |
selective serotonine
(2 times)
|
Pharmacology
(1 time)
|
SNRI (2 times)
PPHN (1 time)
RCTs (1 time)
|
2009 Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008.
|
| 11 |
Sjogren's Syndrome Responder Index
(2 times)
|
Allergy and Immunology
(1 time)
|
pSS (2 times)
BCD (1 time)
SG (1 time)
|
2016 Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjogren's syndrome.
|
| 12 |
sliding-scale regular insulin
(2 times)
|
Endocrinology
(2 times)
|
ENT (1 time)
ICU (1 time)
|
2007 Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: a randomized clinical trial.
|
| 13 |
linezolid-selective serotonin inhibitor
(1 time)
|
Medicine
(1 time)
|
MAOIs (1 time)
|
2006 Anticipating potential linezolid-SSRI interactions in the general hospital setting: an MAOI in disguise.
|
| 14 |
Salt stress response indices
(1 time)
|
|
EC (1 time)
PCA (1 time)
|
2019 Evaluating rice for salinity using pot-culture provides a systematic tolerance assessment at the seedling stage.
|
| 15 |
Schutte Self-Report Inventory of Emotional Intelligence
(1 time)
|
Psychiatry
(1 time)
|
EI (1 time)
NEO-FFI (1 time)
|
2005 Incremental validity of a measure of emotional intelligence.
|
| 16 |
Selective Serotonergic
(1 time)
|
Psychiatry
(1 time)
|
ASA (1 time)
BDNF (1 time)
CGI (1 time)
|
2017 Selective Serotonergic (SSRI) Versus Noradrenergic (SNRI) Reuptake Inhibitors with and without Acetylsalicylic Acid in Major Depressive Disorder.
|
| 17 |
Selective Serotonin Reabsorption Inhibition
(1 time)
|
Neurology
(1 time)
|
---
|
1997 [Panic and depression: early diagnosis of risk patients, early therapy with SSRI (Selective Serotonin Reabsorption Inhibition)].
|
| 18 |
Selective SRI
(1 time)
|
Mental Disorders
(1 time)
|
CGI (1 time)
DRSP (1 time)
IDS-C (1 time)
|
2015 Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
|
| 19 |
self-selected rest interval
(1 time)
|
Physical Fitness
(1 time)
|
CMJ (1 time)
FRI (1 time)
PAP (1 time)
|
2018 Self-Selected Rest Interval Improves Vertical Jump Post-Activation Potentiation.
|
| 20 |
serotonergic antidepressant nefazodone
(1 time)
|
Neurology
(1 time)
|
CBT (1 time)
GC (1 time)
PL (1 time)
|
2005 [Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study].
|
| 21 |
serotonin and adrenaline re-uptake selective inhibitors
(1 time)
|
Medicine
(1 time)
|
---
|
2009 [Post-surgical neuropathic pain].
|
| 22 |
serotonin and serotonin norepinephrine reuptake inhibitors
(1 time)
|
Allergy and Immunology
(1 time)
|
NO (1 time)
TNF-alpha (1 time)
|
2012 A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia.
|
| 23 |
serotonin reuptake inhibitors were most commonly consumed
(1 time)
|
Medicine
(1 time)
|
WMH-CIDI (1 time)
|
2005 [Psychotropic drug use in the Belgian non-institutionalized population].
|
| 24 |
serotonin uptake were administered
(1 time)
|
Psychiatry
(1 time)
|
RIMA (1 time)
|
1994 [Depressive states in old age and their therapy--1983-1993 survey].
|
| 25 |
serotoninergic antidepressant
(1 time)
|
Brain
(1 time)
|
ADs (1 time)
ICF (1 time)
ICI (1 time)
|
2010 Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients.
|
| 26 |
serotoninergic antidepressive drugs
(1 time)
|
Neurology
(1 time)
|
---
|
2007 [Contribution of pubertal psychobiological processes to the formation and clinical manifestations of juvenile depressions].
|
| 27 |
sertraline and escitalopram
(1 time)
|
Psychiatry
(1 time)
|
EPS (1 time)
|
2006 Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report.
|
| 28 |
sexual function was investigated during treatment with escitalopram
(1 time)
|
Psychiatry
(1 time)
|
SD (1 time)
SSRIs (1 time)
|
2011 Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
|
| 29 |
sheep model of PPHN and that selective 5-HT reuptake inhibitor
(1 time)
|
Pulmonary Medicine
(1 time)
|
PPHN (1 time)
PVR (1 time)
|
2013 Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn.
|
| 30 |
short-term effectiveness of psychopharmacological treatment
(1 time)
|
Pediatrics
(1 time)
|
RCT (1 time)
|
2006 [Psychotherapy for anxiety disorders in childhood and adolescence--what is evidence-based?].
|
| 31 |
signal comparably to the selective 5-HT uptake inhibitor
(1 time)
|
Neurology
(1 time)
|
---
|
1999 5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus.
|
| 32 |
significant differences in DM/DX
(1 time)
|
Psychopharmacology
(1 time)
|
DM/DX (1 time)
|
1999 CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.
|
| 33 |
silique shattering resistance index
(1 time)
|
Botany
(1 time)
|
RJAI (1 time)
|
2015 A large replum-valve joint area is associated with increased resistance to pod shattering in rapeseed.
|
| 34 |
similar administration of the selective 5-HT reuptake inhibitor
(1 time)
|
Neurology
(1 time)
|
---
|
1997 The Effect of Selective Serotonin Releasing Agents in the Chronic Mild Stress Model of Depression in Rats.
|
| 35 |
single-dose, overencapsulated 10-mg doses of escitalopram
(1 time)
|
Physical Medicine
(1 time)
|
---
|
2015 Increased Lower Limb Spasticity but Not Strength or Function Following a Single-Dose Serotonin Reuptake Inhibitor in Chronic Stroke.
|
| 36 |
SS Responder Index
(1 time)
|
Rheumatology
(1 time)
|
pSS (1 time)
TEARS (1 time)
|
2015 Development of the Sjogren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.
|
| 37 |
studies with the selective 5-HT reuptake inhibitor
(1 time)
|
Neurology
(1 time)
|
AMPA (1 time)
DA (1 time)
NE (1 time)
|
2018 Partial inhibition of catecholamine activity and enhanced responsiveness to NMDA after sustained administration of vortioxetine.
|
| 38 |
study the effect of Escitalopram
(1 time)
|
Mental Disorders
(1 time)
|
HAM-D (1 time)
SSRIs (1 time)
|
2013 Diabetes with comorbid depression: role of SSRI in better glycemic control.
|
| 39 |
study, we evaluated the effect of escitalopram
(1 time)
|
Pharmacology
(1 time)
|
---
|
2016 The effect of combined treatment with escitalopram and risperidone on the MK-801-induced changes in the object recognition test in mice.
|
| 40 |
substrate for 5-HT and selective 5-HT reuptake inhibitor
(1 time)
|
Neurology
(1 time)
|
SNr (1 time)
|
2015 Robust presynaptic serotonin 5-HT(1B) receptor inhibition of the striatonigral output and its sensitization by chronic fluoxetine treatment.
|
| 41 |
suicide risk between antidepressants
(1 time)
|
Brain
(1 time)
|
RCT (1 time)
|
2005 [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
|
| 42 |
systolic volumes both before and after coronary ligation
(1 time)
|
Cardiology
(1 time)
|
MI (1 time)
|
2013 Impact of neonatal sertraline exposure on the post-myocardial infarction outcomes of adult male mice.
|
A Search Service for Abbreviation / Long Form